Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Development of a nanoparticulate formulation of retinoic acid that suppresses Th17 cells and upregulates regulatory T cells.

Capurso NA, Look M, Jeanbart L, Nowyhed H, Abraham C, Craft J, Fahmy TM.

Self Nonself. 2010 Oct;1(4):335-340.

2.

PLGA nanoparticles enhance the expression of retinaldehyde dehydrogenase enzymes in dendritic cells and induce FoxP3(+) T-cells in vitro.

Keijzer C, Spiering R, Silva AL, van Eden W, Jiskoot W, Vervelde L, Broere F.

J Control Release. 2013 May 28;168(1):35-40. doi: 10.1016/j.jconrel.2013.02.027. Epub 2013 Mar 14.

PMID:
23500056
4.

Retinoid X receptor agonists modulate Foxp3⁺ regulatory T cell and Th17 cell differentiation with differential dependence on retinoic acid receptor activation.

Takeuchi H, Yokota-Nakatsuma A, Ohoka Y, Kagechika H, Kato C, Song SY, Iwata M.

J Immunol. 2013 Oct 1;191(7):3725-33. doi: 10.4049/jimmunol.1300032. Epub 2013 Aug 26.

5.

The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease.

Afzali B, Lombardi G, Lechler RI, Lord GM.

Clin Exp Immunol. 2007 Apr;148(1):32-46. Review.

6.

Alloreactive regulatory T cells generated with retinoic acid prevent skin allograft rejection.

Moore C, Tejon G, Fuentes C, Hidalgo Y, Bono MR, Maldonado P, Fernandez R, Wood KJ, Fierro JA, Rosemblatt M, Sauma D, Bushell A.

Eur J Immunol. 2015 Feb;45(2):452-63. doi: 10.1002/eji.201444743. Epub 2014 Dec 2.

7.

Bacillus-derived poly-γ-glutamic acid reciprocally regulates the differentiation of T helper 17 and regulatory T cells and attenuates experimental autoimmune encephalomyelitis.

Lee K, Hwang S, Paik DJ, Kim WK, Kim JM, Youn J.

Clin Exp Immunol. 2012 Oct;170(1):66-76. doi: 10.1111/j.1365-2249.2012.04637.x.

8.

Th17 cells are restrained by Treg cells via the inhibition of interleukin-6 in patients with rheumatoid arthritis responding to anti-tumor necrosis factor antibody therapy.

McGovern JL, Nguyen DX, Notley CA, Mauri C, Isenberg DA, Ehrenstein MR.

Arthritis Rheum. 2012 Oct;64(10):3129-38. doi: 10.1002/art.34565.

9.

The nuclear receptor PPAR gamma selectively inhibits Th17 differentiation in a T cell-intrinsic fashion and suppresses CNS autoimmunity.

Klotz L, Burgdorf S, Dani I, Saijo K, Flossdorf J, Hucke S, Alferink J, Nowak N, Beyer M, Mayer G, Langhans B, Klockgether T, Waisman A, Eberl G, Schultze J, Famulok M, Kolanus W, Glass C, Kurts C, Knolle PA.

J Exp Med. 2009 Sep 28;206(10):2079-89. doi: 10.1084/jem.20082771. Epub 2009 Sep 8. Erratum in: J Exp Med. 2009 Dec 21;206(13):3159. Novak, Natalija [corrected to Nowak, Nina].

10.

Oral administration of retinoic acid receptor-alpha/beta-specific ligand Am80 suppresses experimental autoimmune uveoretinitis.

Keino H, Watanabe T, Sato Y, Okada AA.

Invest Ophthalmol Vis Sci. 2011 Mar 1;52(3):1548-56. doi: 10.1167/iovs.10-5963.

PMID:
20861477
11.

Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells.

Luz-Crawford P, Kurte M, Bravo-Alegría J, Contreras R, Nova-Lamperti E, Tejedor G, Noël D, Jorgensen C, Figueroa F, Djouad F, Carrión F.

Stem Cell Res Ther. 2013 Jun 4;4(3):65. doi: 10.1186/scrt216.

12.

Ex vivo IL-1 receptor type I expression in human CD4+ T cells identifies an early intermediate in the differentiation of Th17 from FOXP3+ naive regulatory T cells.

Raffin C, Raimbaud I, Valmori D, Ayyoub M.

J Immunol. 2011 Nov 15;187(10):5196-202. doi: 10.4049/jimmunol.1101742. Epub 2011 Oct 12.

13.

Retinoic acid attenuates acute heart rejection by increasing regulatory T cell and repressing differentiation of Th17 cell in the presence of TGF-β.

Wang G, Zhong A, Wang S, Dong N, Sun Z, Xia J.

Transpl Int. 2010 Oct;23(10):986-97. doi: 10.1111/j.1432-2277.2010.01080.x.

14.

Co-association of methotrexate and SPIONs into anti-CD64 antibody-conjugated PLGA nanoparticles for theranostic application.

Moura CC, Segundo MA, Neves Jd, Reis S, Sarmento B.

Int J Nanomedicine. 2014 Oct 23;9:4911-22. doi: 10.2147/IJN.S68440. eCollection 2014.

15.

IDO upregulates regulatory T cells via tryptophan catabolite and suppresses encephalitogenic T cell responses in experimental autoimmune encephalomyelitis.

Yan Y, Zhang GX, Gran B, Fallarino F, Yu S, Li H, Cullimore ML, Rostami A, Xu H.

J Immunol. 2010 Nov 15;185(10):5953-61. doi: 10.4049/jimmunol.1001628. Epub 2010 Oct 13.

16.

ERK differentially regulates Th17- and Treg-cell development and contributes to the pathogenesis of colitis.

Liu H, Yao S, Dann SM, Qin H, Elson CO, Cong Y.

Eur J Immunol. 2013 Jul;43(7):1716-26. doi: 10.1002/eji.201242889. Epub 2013 Jun 3.

17.

IL-4 and retinoic acid synergistically induce regulatory dendritic cells expressing Aldh1a2.

Zhu B, Buttrick T, Bassil R, Zhu C, Olah M, Wu C, Xiao S, Orent W, Elyaman W, Khoury SJ.

J Immunol. 2013 Sep 15;191(6):3139-51. doi: 10.4049/jimmunol.1300329. Epub 2013 Aug 19.

18.

Overexpression of a minimal domain of calpastatin suppresses IL-6 production and Th17 development via reduced NF-κB and increased STAT5 signals.

Iguchi-Hashimoto M, Usui T, Yoshifuji H, Shimizu M, Kobayashi S, Ito Y, Murakami K, Shiomi A, Yukawa N, Kawabata D, Nojima T, Ohmura K, Fujii T, Mimori T.

PLoS One. 2011;6(10):e27020. doi: 10.1371/journal.pone.0027020. Epub 2011 Oct 27.

19.

Modulation of autoimmune diseases by interleukin (IL)-17 producing regulatory T helper (Th17) cells.

Singh B, Schwartz JA, Sandrock C, Bellemore SM, Nikoopour E.

Indian J Med Res. 2013 Nov;138(5):591-4. Review.

20.

Biodegradable nanoparticle mediated antigen delivery to human cord blood derived dendritic cells for induction of primary T cell responses.

Diwan M, Elamanchili P, Lane H, Gainer A, Samuel J.

J Drug Target. 2003;11(8-10):495-507.

PMID:
15203918
Items per page

Supplemental Content

Write to the Help Desk